Skip to content
Independent analysis of NHS open data
PharmaInsight

Vedolizumab

Gastro-Intestinal System Chronic bowel disorders BNF 0105030A0
Data updated February 2025 Download CSV
1items

Dispensed in February 2025

0items

Rolling 12 months

£2,050

Net ingredient cost · February 2025

Figure 1. Vedolizumab: national items dispensed by month

0 1 2 May 2022 Jan 2024 Jul 2024 Sep 2024 Dec 2024 Jan 2025 Feb 2025 1 May 2022: 1 Jan 2024: 1 Jul 2024: 1 Sep 2024: 2 Dec 2024: 1 Jan 2025: 1 Feb 2025: 1

Source: NHSBSA Prescription Cost Analysis, to February 2025

Download CSV
Embed this chart

At a glance

  • Therapeutic class Chronic bowel disorders
  • Presentations 1 shown
  • Average cost / item £2,050.00
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, February 2025

The individual products dispensed under Vedolizumab this month.

Presentations of Vedolizumab, February 2025
Presentation BNF code Items Net ingredient cost
Entyvio 300mg pdr for concentrate for inf vials 0105030A0BBAAAA 1 £2,050

Source: NHSBSA Prescription Cost Analysis · to February 2025 OGL v3.0

Where Vedolizumab is dispensed

The regions and dispensing practices with the highest Vedolizumab volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

In NHS hospitals

Vedolizumab is also used in NHS secondary care. See the indicative hospital cost, monthly trend and the trusts using it most on the hospital medicines page.

Compare Vedolizumab with

Other medicines in the same BNF section, by prescribing volume.